• UroGen Pharma (NASDAQ:URGN) Receives Buy Rating from HC Wainwright

    Source: Buzz FX / 25 Feb 2025 08:11:19   America/New_York


    UroGen Pharma (NASDAQ:URGN) Receives Buy Rating from HC Wainwright Written by MarketBeat February 25, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reiterated by investmen
    Read more...
Share on,